Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease

Torrence, Anne E; Brabb, Thea; Viney, Joanne L.; Bielefeldt‐Ohmann, Helle; Treuting, Piper M.; Seamons, Audrey; Drivdahl, Rolf H.; Zeng, Weiping; Maggio‐Price, Lillian

doi:10.1002/ibd.20347

Cited by 28 publications

(24 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In the present study, we observed that plasma levels of MMP-9 but not MMP-2 were increased early in abdominal sepsis. This observation is in line with other studies reporting that MMP-9 levels are elevated in the circulation of infectious disease models [40,41]. We next investigated whether MMP-9 might be involved in platelet shedding of CD40L in sepsis.…”

Section: Discussionsupporting

confidence: 90%

Platelet shedding of CD40L is regulated by matrix metalloproteinase‐9 in abdominal sepsis

Rahman

Zhang

Chew

et al. 2013

Journal of Thrombosis and Haemostasis

View full text Add to dashboard Cite

To cite this article: Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis. J Thromb Haemost 2013; 11: 1385-98.Summary. Background and objectives: Platelet-derived CD40L is known to regulate neutrophil recruitment and lung damage in sepsis. However, the mechanism regulating shedding of CD40L from activated platelets is not known. We hypothesized that matrix metalloproteinase (MMP)-9 might cleave surface-expressed CD40L and regulate pulmonary accumulation of neutrophils in sepsis. Methods: Abdominal sepsis was induced by cecal ligation and puncture (CLP) in wild-type and MMP-9-deficient mice. Edema formation, CXC chemokine levels, myeloperoxidase levels, neutrophils in the lung and plasma levels of CD40L and MMP-9 were quantified. Results: CLP increased plasma levels of MMP-9 but not MMP-2. The CLP-induced decrease in platelet surface CD40L and increase in soluble CD40L levels were significantly attenuated in MMP-9 gene-deficient mice. Moreover, pulmonary myeloperoxidase (MPO) activity and neutrophil infiltration in the alveolar space, as well as edema formation and lung injury, were markedly decreased in septic mice lacking MMP-9. In vitro studies revealed that inhibition of MMP-9 decreased platelet shedding of CD40L. Moreover, recombinant MMP-9 was capable of cleaving surface-expressed CD40L on activated platelets. In human studies, plasma levels of MMP-9 were significantly increased in patients with septic shock as compared with healthy controls, although MMP-9 levels did not correlate with organ injury score. Conclusions: Our novel data propose a role of MMP-9 in regulating platelet-dependent infiltration of neutrophils and tissue damage in septic lung injury by controlling CD40L shedding from platelets. We conclude that targeting MMP-9 may be a useful strategy to limit acute lung injury in abdominal sepsis.

show abstract

Section: Discussionsupporting

confidence: 90%

Platelet shedding of CD40L is regulated by matrix metalloproteinase‐9 in abdominal sepsis

Rahman

Zhang

Chew

et al. 2013

Journal of Thrombosis and Haemostasis

View full text Add to dashboard Cite

show abstract

“…10 Using both ELISA and western blot, we observed herein that plasma levels of MMP-9 were increased in abdominal sepsis. This finding is in accordance with other investigations showing enhanced MMP-9 levels in the circulation of sepsis and infectious disease models, [37][38][39] as well as in patients with sepsis. 10,40 Notably, it was observed that administration of NSC23766 significantly decreased the sepsis-induced increase of MMP-9 levels in plasma, indicating that Rac1 might be an important regulator of systemic levels of MMP-9 in abdominal sepsis.…”

Section: Discussionsupporting

confidence: 82%

Rac1 regulates platelet shedding of CD40L in abdominal sepsis

Hwaiz

Rahman

Zhang

et al. 2014

Laboratory Investigation

View full text Add to dashboard Cite

Matrix metalloproteinase-9 (MMP-9) regulates platelet shedding of CD40L in abdominal sepsis. However, the signaling mechanisms controlling sepsis-induced shedding of CD40L from activated platelets remain elusive. Rac1 has been reported to regulate diverse functions in platelets; we hypothesized herein that Rac1 might regulate platelet shedding of CD40L in sepsis. The specific Rac1 inhibitor NSC23766 (N6-[2-[[4-(diethylamino)-1-methylbutyl] amino]-6-methyl-4-pyrimidinyl]-2 methyl-4, 6-quinolinediamine trihydrochloride) was administered to mice undergoing cecal ligation and puncture (CLP). Levels of CD40L and MMP-9 in plasma, platelets, and neutrophils were determined by use of ELISA, western blot, and confocal microscopy. Platelet depletion abolished the CLP-induced increase in plasma levels of CD40L. Rac1 activity was significantly increased in platelets from septic animals. Administration of NSC23766 abolished the CLP-induced enhancement of soluble CD40L levels in the plasma. Moreover, Rac1 inhibition completely inhibited proteinase-activated receptor-4-induced surface mobilization and secretion of CD40L in isolated platelets. CLP significantly increased plasma levels of MMP-9 and Rac1 activity in neutrophils. Treatment with NSC23766 markedly attenuated MMP-9 levels in the plasma from septic mice. In addition, Rac1 inhibition abolished chemokine-induced secretion of MMP-9 from isolated neutrophils. Finally, platelet shedding of CD40L was significantly reduced in response to stimulation with supernatants from activated MMP-9-deficient neutrophils compared with supernatants from wild-type neutrophils, indicating a direct role of neutrophil-derived MMP-9 in regulating platelet shedding of CD40L. Our novel data suggest that sepsis-induced platelet shedding of CD40L is dependent on Rac1 signaling. Rac1 controls surface mobilization of CD40L on activated platelets and MMP-9 secretion from neutrophils. Thus, our findings indicate that targeting Rac1 signaling might be a useful way to control pathologic elevations of CD40L in the systemic circulation in abdominal sepsis.

show abstract

“…Previous clinical and animal studies have demonstrated that the lymphotactin-XCR interaction contributes in the pathogenesis of inflammatory diseases, including rheumatoid arthritis, systemic sclerosis, inflammatory bowel disease, glomerulonephritis and HIV infection [17][18][19][20][21][22]. In the eye, upregulation of lymphotactin expression is found in the mouse cornea after mechanical trauma or endotoxin exposure, and may be related to early corneal graft rejection [23].…”

Section: Introductionmentioning

confidence: 98%

Expressions of lymphotactin and its receptor, XCR, in Lewis rats with experimental autoimmune anterior uveitis

Yeh

Lin

et al. 2010

Graefes Arch Clin Exp Ophthalmol

View full text Add to dashboard Cite

show abstract

Serum biomarkers in a mouse model of bacterial-induced inflammatory bowel disease

Abstract: Serum analyte measurement is a useful, noninvasive method for monitoring disease in a mouse model of bacterial-induced IBD.

Cited by 28 publications

References 36 publications

Platelet shedding of CD40L is regulated by matrix metalloproteinase‐9 in abdominal sepsis

Platelet shedding of CD40L is regulated by matrix metalloproteinase‐9 in abdominal sepsis

Rac1 regulates platelet shedding of CD40L in abdominal sepsis

Expressions of lymphotactin and its receptor, XCR, in Lewis rats with experimental autoimmune anterior uveitis

Contact Info

Product

Resources

About